STOCK TITAN
  1. Home
  2. News
  3. MDT

Medtronic Plc - MDT STOCK NEWS

Welcome to our dedicated news page for Medtronic Plc (Ticker: MDT), a resource for investors and traders seeking the latest updates and insights on Medtronic Plc.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Medtronic Plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Medtronic Plc's position in the market.

News
Americans favor quality over quantity in pursuit of longevity
Rhea-AI Summary
A new survey from Medtronic and Morning Consult reveals that nearly two-thirds of U.S. adults prioritize a shorter, healthier life over a longer one with health issues. This shift towards quality over quantity in pursuit of longevity reflects changing attitudes towards health and well-being.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care
Rhea-AI Summary
Medtronic plc announced the launch of ColonPRO™ software for the GI Genius™ intelligent endoscopy system, enhancing AI-driven polyp detection with a 9% reduction in false positives. The collaboration with Modernizing Medicine® aims to streamline workflows and improve patient care in endoscopic procedures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.75%
Tags
AI
-
News
New Documentary Released by Medtronic: "A Voice for Health"
Rhea-AI Summary
Medtronic LABS aims to expand access to essential healthcare in Kenya, showcasing their mission through a documentary 'A Voice for Health'.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.95%
Tags
none
News
The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation
Rhea-AI Summary
Medtronic plc (MDT) announces positive clinical trial results for Sphere-360 catheter, showing high efficacy and safety in treating atrial fibrillation. The catheter, fully integrated with Affera™ Mapping and Ablation System, demonstrated 81.8% freedom from atrial arrhythmias after one year of follow-up. The study also highlighted 100% freedom in the sub-group treated with the optimized pulse configuration, with a treatment time of 10 minutes on average. The Sphere-360 catheter showed 96% sustained lesion durability in patients treated with the optimized pulse. The innovative design of the catheter allows for efficient energy delivery, tissue-conformable lattice tip, and compatibility with various PV anatomies. The study emphasized the catheter's safety profile with zero primary safety adverse events.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.95%
Tags
none
-
News
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
Rhea-AI Summary
Medtronic plc (MDT) announces positive results from the largest head-to-head TAVR trial, showing non-inferior clinical outcomes and superior valve performance for Evolut TAVR compared to Sapien at one year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
New survey uncovers lack of awareness around heart valve disease and risk factors among women
Rhea-AI Summary
Medtronic plc unveils topline findings of a survey on women's perceptions and knowledge of heart valve disease, emphasizing the need for increased awareness, early detection, and access to appropriate care for women at risk.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis
Rhea-AI Summary
Medtronic plc (NYSE: MDT) receives FDA approval for the Evolut™ FX+ TAVR system, enhancing valve performance with larger coronary access windows for treating symptomatic severe aortic stenosis. The system maintains market-leading valve benefits while offering improved catheter maneuverability for diverse patient anatomies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.85%
Tags
fda approval
-
News
U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents
Rhea-AI Summary
Medtronic (MDT) wins PTAB affirmation of patent claims in ongoing infringement lawsuit against Axonics, plans to proceed to trial on five upheld patents.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.75%
Tags
none
-
News
New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management
Rhea-AI Summary
Medtronic plc. (NYSE: MDT) presents new data at ATTD showcasing the MiniMed™ 780G system's ability to help individuals with type 1 diabetes surpass international targets on outcome measures. The data reveals that users achieved a Time in Tight Range (TITR) of over 56%, exceeding the recommended goal of 50%. The system has shown remarkable success in improving Time in Range and moving users closer to euglycemia, enhancing overall health outcomes for people with diabetes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Medtronic announces cash dividend for fourth quarter of fiscal year 2024
Rhea-AI Summary
Medtronic plc (MDT) board authorizes $5 billion for share repurchases, consistent with its history of increasing dividends for 46 years. The dividend of $0.69 per share is payable on April 12, 2024, to shareholders of record on March 22, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.02%
Tags
dividends earnings
Stock MDT logo
Medtronic Plc

NYSE:MDT

MDT Rankings

#107 Ranked by Market Cap
#3364 Ranked by Stock Gains
#1010 Ranked by Dividends

MDT Stock Data

106.40B
1.33B
0.11%
85.18%
0.94%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
US
Minneapolis

About MDT

Medtronic plc is an American medical device company. The companys operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015.